Drugs News and Research

RSS

Uncontrolled hypertension wreaks havoc on global health and economies

The World Health Organization's recent report underscores the global health and economic crisis posed by uncontrolled hypertension, affecting one in five people worldwide. The study calls for urgent, coordinated government action, emphasizing that effective hypertension management could prevent millions of deaths and offer an 18-to-1 return on investment.

20 Sep 2023

Nanotechnology-based strategies for preventing, treating, and diagnosing viral infections

Newly emerging and recurrent cases of viral infections constitute a significant problem and a huge challenge to public health.

20 Sep 2023

New near-infrared activated photo-oxidants kill cancer cells without oxygen

A research team led by scientists from City University of Hong Kong (CityU) has achieved a significant breakthrough by inventing a new class of near-infrared-activated photo-oxidants that can effectively kill cancer cells without requiring oxygen.

20 Sep 2023

New study sheds light on vitamin D's role in cardiovascular health

Researchers conducted a prospective population-based analysis to understand whether vitamin D levels were associated with cardiovascular disease events and mortality, and overall mortality.

20 Sep 2023

Transforming postpartum depression treatment with neurosteroids

A new study in Neuropsychopharmacology delves into the mechanisms of action of brexanolone, the first FDA-approved, rapid-acting antidepressant specifically for postpartum depression (PPD). The research highlights brexanolone's potential anti-inflammatory effects and its impact on GABAA receptors, offering insights into its efficacy and suggesting avenues for further study.

19 Sep 2023

Amoxicillin vs. amoxicillin-clavulanate: Which is more effective for acute sinusitis in children?

Brigham researchers found that patients prescribed amoxicillin-clavulanate had higher rates of gastrointestinal symptoms and yeast infections than those prescribed amoxicillin.

19 Sep 2023

CDC awards $17.5M to UC San Diego-led coalition to develop innovative outbreak response tools

The Centers for Disease Control and Prevention (CDC) has awarded $17.5 million to a coalition led by researchers at UC San Diego to develop innovative tools and networks to respond rapidly to emerging disease outbreaks.

19 Sep 2023

Using both cannabis and tobacco linked to higher rates of depression and anxiety

People who use both cannabis and tobacco have significantly higher rates of depression and anxiety than those who use either substance alone or not at all, according to a new study by UC San Francisco researchers.

19 Sep 2023

Vaping increases the risk of asthma in adolescents, study suggests

A new study from the Texas A&M University School of Public Health suggests that vaping increases the risk of asthma in adolescents who have never smoked conventional tobacco products.

19 Sep 2023

The importance of using the American Heart Association-recommended technique for blood pressure measurement

A modified cross-over design to compare methods of taking blood pressure readings.

19 Sep 2023

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment.

19 Sep 2023

New treatment approach effectively treats the most aggressive forms of prostate cancer

Researchers at the University of Chicago Medicine Comprehensive Cancer Center established "proof-of-concept" for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer. The treatment showed complete tumor control and long-lasting survival without side effects in a mouse model of advanced prostate cancer.

19 Sep 2023

Adaptive platform trial shows promise for finding new glioblastoma therapies

An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.

19 Sep 2023

Nano-based cancer therapies may be less effective in younger patients, finds study

Researchers at The University of Texas MD Anderson Cancer Center have discovered that certain nano-based cancer therapies may be less effective in younger patients, highlighting the need for further investigation into the impact of aging on the body's ability to respond to treatment.

19 Sep 2023

Cancer drug could play a role in limiting the damaging effects of lung disease in COVID-19 patients

A cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients, thanks to new research at Hudson Institute of Medical Research.

19 Sep 2023

New implantable device carries insulin-producing islet cells to control diabetes

One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent insulin injections.

19 Sep 2023

Researchers identify key mechanisms to address future treatments for hereditary blindness

There are still many enigmas about the mechanism of action of the CERKL gene, which causes retinitis pigmentosa and other hereditary vision diseases.

18 Sep 2023

COVID-19 pandemic fails to deter osteoporosis treatment initiation: New study reveals steady rates

Whether patients with newly diagnosed osteoporosis received delayed pharmacologic treatment due to the COVID-19 pandemic.

18 Sep 2023

UK Markey Cancer Center becomes NCI-Designated Comprehensive Cancer Center

The University of Kentucky Markey Cancer Center announced today that it has earned a National Cancer Institute "Comprehensive" Cancer Center designation, the highest level of recognition awarded by the NCI. Markey is the first and only center in Kentucky to achieve this designation, and the next-closest Comprehensive Cancer Center is nearly 200 miles from Lexington.

15 Sep 2023

Study upends common belief in what triggers Parkinson's disease

A new Northwestern Medicine study challenges a common belief in what triggers Parkinson's disease.

15 Sep 2023

Drugs News and Research

Uncontrolled hypertension wreaks havoc on global health and economies

Nanotechnology-based strategies for preventing, treating, and diagnosing viral infections

New near-infrared activated photo-oxidants kill cancer cells without oxygen

New study sheds light on vitamin D's role in cardiovascular health

Transforming postpartum depression treatment with neurosteroids

Amoxicillin vs. amoxicillin-clavulanate: Which is more effective for acute sinusitis in children?

CDC awards $17.5M to UC San Diego-led coalition to develop innovative outbreak response tools

Using both cannabis and tobacco linked to higher rates of depression and anxiety

Vaping increases the risk of asthma in adolescents, study suggests

The importance of using the American Heart Association-recommended technique for blood pressure measurement

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

New treatment approach effectively treats the most aggressive forms of prostate cancer

Adaptive platform trial shows promise for finding new glioblastoma therapies

Nano-based cancer therapies may be less effective in younger patients, finds study

Cancer drug could play a role in limiting the damaging effects of lung disease in COVID-19 patients

New implantable device carries insulin-producing islet cells to control diabetes

Researchers identify key mechanisms to address future treatments for hereditary blindness

COVID-19 pandemic fails to deter osteoporosis treatment initiation: New study reveals steady rates

UK Markey Cancer Center becomes NCI-Designated Comprehensive Cancer Center

Study upends common belief in what triggers Parkinson's disease

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News